$ Value
$0
Shares
16,158
Price
$0
Filed
Aug 20
Insider
Name
Hopman Mark
Title
Chief Commercial Officer
CIK
0002048497
Roles
Transaction Details
Transaction Date
2025-08-19
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
67,084
Footnotes
Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 13, 2025. | The weighted average sale price for the transaction reported was $16.6095 and the range of prices were between $16.26 and $17.1719. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. | One-fourth of the shares subject to this option shall vest one year after March 20, 2023, and thereafter 1/36th of the shares subject to this option shall vest on each monthly anniversary thereof.
Filing Info
Hopman Mark's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-04 | BBNX | ▼ | $4K |
| 2026-03-02 | BBNX | ▼ | $10K |
| 2026-02-27 | BBNX | A | $0 |
| 2026-02-27 | BBNX | A | $0 |
| 2026-02-27 | BBNX | A | $0 |
| 2025-12-04 | BBNX | ▼ | $63K |
| 2025-12-02 | BBNX | ▼ | $25K |
| 2025-09-05 | BBNX | M | $58K |
| 2025-09-05 | BBNX | ▼ | $235K |
| 2025-09-05 | BBNX | M | $0 |
Other Insiders at BBNX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Hopman Mark
Chief Commercial Officer
|
— | $103K | 2026-03-04 |
|
Mensinger Mike
Chief Product Officer
|
— | $13K | 2026-03-02 |
|
Feider Stephen
Chief Financial Officer
|
— | $18K | 2026-03-02 |
|
Saint Sean
President & CEO
|
— | $42K | 2026-03-02 |
|
Russell Steven Jon
Chief Medical Officer
|
— | $43K | 2026-03-02 |